GB9722604D0 - Heparin-binding growth factor derivatives - Google Patents

Heparin-binding growth factor derivatives

Info

Publication number
GB9722604D0
GB9722604D0 GBGB9722604.7A GB9722604A GB9722604D0 GB 9722604 D0 GB9722604 D0 GB 9722604D0 GB 9722604 A GB9722604 A GB 9722604A GB 9722604 D0 GB9722604 D0 GB 9722604D0
Authority
GB
United Kingdom
Prior art keywords
heparin
growth factor
binding growth
factor derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9722604.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Priority to GBGB9722604.7A priority Critical patent/GB9722604D0/en
Publication of GB9722604D0 publication Critical patent/GB9722604D0/en
Priority to AU10391/99A priority patent/AU1039199A/en
Priority to PCT/GB1998/003201 priority patent/WO1999021588A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9722604.7A 1997-10-28 1997-10-28 Heparin-binding growth factor derivatives Ceased GB9722604D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9722604.7A GB9722604D0 (en) 1997-10-28 1997-10-28 Heparin-binding growth factor derivatives
AU10391/99A AU1039199A (en) 1997-10-28 1998-10-28 Heparin-binding growth factor derivatives
PCT/GB1998/003201 WO1999021588A1 (en) 1997-10-28 1998-10-28 Heparin-binding growth factor derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9722604.7A GB9722604D0 (en) 1997-10-28 1997-10-28 Heparin-binding growth factor derivatives

Publications (1)

Publication Number Publication Date
GB9722604D0 true GB9722604D0 (en) 1997-12-24

Family

ID=10821115

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9722604.7A Ceased GB9722604D0 (en) 1997-10-28 1997-10-28 Heparin-binding growth factor derivatives

Country Status (3)

Country Link
AU (1) AU1039199A (en)
GB (1) GB9722604D0 (en)
WO (1) WO1999021588A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7241730B2 (en) 1998-08-27 2007-07-10 Universitat Zurich Enzyme-mediated modification of fibrin for tissue engineering: fibrin formulations with peptides
EP1175235A1 (en) * 1999-04-22 2002-01-30 Eidgenossisch Technische Hochschule Zurich Modified protein matrices
DE69929323T2 (en) * 1999-04-22 2006-09-07 Eidgenössische Technische Hochschule (ETH) CONTROLLED DELIVERY OF THE GROWTH FACTORS OF HEPARINE CONTAINING MATRICES
US20050054560A1 (en) * 2001-08-09 2005-03-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Cd44 variants carrying heparan sulfate chains and uses thereof
SG177002A1 (en) * 2001-10-10 2012-01-30 Novo Nordisk As Remodeling and glycoconjugation of peptides
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
AU2004299992B2 (en) 2003-12-18 2011-03-24 Procognia Ltd. Method for analyzing a glycomolecule
US7517856B2 (en) * 2005-10-11 2009-04-14 Ben-Gurion University Of The Negev Research And Development Authority Bioconjugates comprising sulfated polysaccharides and their uses
EP1886696A1 (en) * 2006-08-03 2008-02-13 Endotis Pharma Conjugates of antithrombin binding oligosaccharide derivatives and therapeutic proteins
JP2012512812A (en) 2007-12-28 2012-06-07 クロス・バイオサージェリー・アクチェンゲゼルシャフト PDGF fusion protein incorporated into fibrin foam
EP2816964B1 (en) 2012-02-21 2023-12-27 Ben-Gurion University of The Negev Research and Development Authority Hydrogel system comprising spatially separated bioactive polypeptides
US20150250822A1 (en) * 2012-10-04 2015-09-10 Genesys Research Institute Platelet compositions and uses thereof
SG11201705602VA (en) * 2015-01-09 2017-08-30 Agency Science Tech & Res Pdgf-b /pdgf-bb binding variants of heparan sulphates
JP7033066B2 (en) 2016-01-07 2022-03-09 ビー．ジー．ネゲブ テクノロジーズ アンド アプリケーションズ リミテッド， アット ベン‐グリオン ユニバーシティー Compositions and Methods to Generate Immune Tolerance Responses
CN112535737A (en) * 2019-09-20 2021-03-23 中国科学院苏州纳米技术与纳米仿生研究所 Bioactive material capable of efficiently combining and exciting bFGF activity function and application thereof
CN110917208B (en) * 2019-12-27 2021-02-12 浙江医院 Application of sulfated mannoglucuronhexaose in preventing and treating atherosclerosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100668A (en) * 1988-06-14 1992-03-31 Massachusetts Institute Of Technology Controlled release systems containing heparin and growth factors
FI921689A (en) * 1991-04-16 1992-10-17 Seikagagu Kogyo Kabushiki Kais OLIGOSACKARID MED AFFINITET FOER FIBROBLASTTILLVAEXTFAKTOR OCH FOERFARANDE FOER FRAMSTAELLNING AV DENNA
JP2855307B2 (en) * 1992-02-05 1999-02-10 生化学工業株式会社 Photoreactive glycosaminoglycans, cross-linked glycosaminoglycans and methods for producing them
GB9206291D0 (en) * 1992-03-23 1992-05-06 Cancer Res Campaign Tech Oligosaccharides having growth factor binding affinity
US5474765A (en) * 1992-03-23 1995-12-12 Ut Sw Medical Ctr At Dallas Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
AU677789B2 (en) * 1992-07-02 1997-05-08 Collagen Corporation Biocompatible polymer conjugates

Also Published As

Publication number Publication date
AU1039199A (en) 1999-05-17
WO1999021588A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
EG24081A (en) 4-Substituted-9-deoxo-9a-aza-9a-homerythromycin derivatives
HUP0003642A3 (en) N-alkanoylphenylalanine derivatives
GB9702194D0 (en) Sulphonide derivatives
ZA987602B (en) N-alkanoylphenylalanine derivatives
PL334847A1 (en) Substituted 3-heterocyclyl-benzoyl derivatives
HU9700358D0 (en) New oxazolidinon derivatives
EG23756A (en) D-proline derivatives
IL125379A0 (en) New 19-nor-pregnene derivatives
HU9801168D0 (en) Triazinylaminostilbene derivatives
GB9722604D0 (en) Heparin-binding growth factor derivatives
SG71173A1 (en) 1,3,8,-triaza-spiro[4,5]decan-4-on derivatives
IL132982A0 (en) Cis-disubstituted aminocycloalkyl-pyrrolidine derivatives
GB9715821D0 (en) Amidino-camptothecin derivatives
GB2321457B (en) 5-Aroylnaphthalene derivatives
ZA98611B (en) Imino-aza-anthracyclinone derivatives
GB9725541D0 (en) Amino-benzothiazole derivatives
ZA985326B (en) Aminospiropiperidine quinazoline derivatives
ZA983116B (en) Arylsecocholadiene derivatives
ZA983168B (en) New naphthylpiperazine derivatives
IL131159A0 (en) 4-Aminoethoxyindazole derivatives
GB9706753D0 (en) Aralkoxy-morphinan derivatives
SI1005445T1 (en) N-alkanoylphenylalanine derivatives
ZA98879B (en) Omega-cycloalkyl-prostaglandin e2 derivatives
ZA983700B (en) 1-galactose derivatives
ZA983692B (en) 1-Thiogalactose derivatives

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)